Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis

Neurology

Volumn 71, Issue 17, 2008, Pages 1326-1334

  Appel, S H ^a   Engelhardt, J I ^b   Henkel, J S ^a   Siklos, L ^c   Beers, D R ^a   Yen, A A ^a   Simpson, E P ^a   Luo, Y ^d   Carrum, G ^e   Heslop, H E ^e   Brenner, M K ^e   Popat, U ^e,f  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

^d HOUSTON METHODIST HOSPITAL   (United States)

^e CENTER FOR CELL AND GENE THERAPY   (United States)

^f UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR2; DNA; FLUDARABINE; HLA ANTIGEN; MESSENGER RNA; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID; T6 ANTIGEN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASSISTED VENTILATION; AUTOPSY; BRAIN STEM; BRAIN TISSUE; CELL COUNT; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CERVICAL SPINAL CORD; CHEMOPROPHYLAXIS; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE RELEASE; DETERIORATION; DISEASE COURSE; DNA DETERMINATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; ENCEPHALITIS; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVING DONOR; MALE; MOTOR NEURON DISEASE; MULTIPLE CYCLE TREATMENT; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RADIATION DOSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIBLING; STEM CELL MOBILIZATION; SURVIVAL; THORACIC SPINAL CORD; TREATMENT OUTCOME; WHOLE BODY RADIATION; COMPARATIVE STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING;

EID: 55449090370     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000327668.43541.22     Document Type: Article

References (32)

1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-1700.
2. Henkel JS, Engelhardt JI, Siklos L, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004;55:221-235.
3. Clement AM, Nguyen MD, Roberts EA, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003;302:113-117.
4. Beers DR, Henkel JS, Xiao Q, et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2006;103:16021-16026.
5. Boillee S, Yamanaka K, Lobsiger CS, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006;312:1389-1392.
6. Yamanaka K, Chun SJ, Boillee S, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008;11:251-253.
7. DiGiorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007; 10:608-614.
8. Nagai M, Re DB, Nagata T, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007;10:615-622.
9. Wada R, Tifft CJ, Proia RL. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci USA 2000;97:10954-10959.
10. Wu YP, McMahon EJ, Matsuda J, Suzuki K, Matsushima GK, Suzuki K. Expression of immune-related molecules is downregulated in twitcher mice following bone marrow transplantation. J Neuropathol Exp Neurol 2001; 60:1062-1074.
11. Priller J, Flugel A, Wehner T, et al. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial en-graftment. Nat Med 2001;7:1356-1361.
12. Biffi A, De Palma M, Quattrini A, et al. Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J Clin Invest 2004;113:1118-1129.
13. Biffi A, Capotondo A, Fasano S, et al. Gene therapy of meta-chromatic leukodystrophy reverses neurological damage and deficits in mice. J Clin Invest 2006;116:3070-3082.
14. Neumann H. Microglia: a cellular vehicle for CNS gene therapy. J Clin Invest 2006;116:2857-2860.
15. Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
16. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-828.
17. Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lym-phohematopoietic transplantation: recommendation from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2001;7:473-485.
18. Czaplinski A, Haverkamp LJ, Yen AA, Simpson EP, Lai EC, Appel SH. The value of database controls in pilot or futility studies in ALS. Neurology 2006;67:1827-1832.
19. Haverkamp L, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population: validation of a scoring system and a model for survival prediction. Brain 1995;118:707-792.
20. Henkel JS, Beers DR, Siklos L, Appel SH. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci 2006;31:427-437.
21. Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD, Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci USA 2003;100:1364-1369.
22. Crain BJ, Tran SD, Mezey E. Transplanted human bone marrow cells generate new brain cells. J Neurol Sci 2005; 233:121-123.
23. Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 2001;57:1282-1289.
24. Almer G, Vukosavic S, Romero N, Przedborski S. Induc-ible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999;72:2415-2425.
25. Mahad D, Callahan MK, Williams KA, et al. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain 2006;129:212-223.
26. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 2001;193:713-726.
27. Solomon JN, Lewis CA, Ajami B, Corbel SY, Rossi FM, Krieger C. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis. Glia 2006;7:744- 753.
28. Corti S, Locatelli F, Donadoni C, et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissue. Brain 2004;127:2518-2532.
29. + cells differentiate into microglia and express recombinant therapeutic protein. Proc Natl Acad Sci USA 2004;101:3557-3562.
30. Silani V, Cova L, Corbo M, Ciammola A, Polli E. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004; 364:200-202.
31. Samijn JP, te Boekhorst PA, Mondria T, et al. Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neu-rosurg Psychiatry 2006;77:46-50.
32. Williams DA, Baum C. Gene therapy: new challenges ahead. Science 2003;302:400-401.